Participants 69 120 7
218 patients with a median follow-up of eight years
Participants 276 407 5
patients with advanced stage Hodgkin's disease (HD), as well as in early stage patients with systemic symptoms and/or bulky disease
Participants 428 469 9
218 patients with previously untreated HD
Participants 1105 1143 3
patients who entered the ABVD/MOPP arm
